BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 18443637)

  • 1. Opioid pharmacology.
    Trescot AM; Datta S; Lee M; Hansen H
    Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu opioid receptor antagonists: recent developments.
    Goodman AJ; Le Bourdonnec B; Dolle RE
    ChemMedChem; 2007 Nov; 2(11):1552-70. PubMed ID: 17918759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low efficacy opioids: implications for sex differences in opioid antinociception.
    Barrett AC
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):1-11. PubMed ID: 16503700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
    Zhao M; Joo DT
    Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
    Zuurmond WW; Meert TF; Noorduin H
    Acta Anaesthesiol Belg; 2002; 53(3):193-201. PubMed ID: 12461829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
    Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
    Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of opioids in the elderly -- pharmacokinetic and pharmacodynamic considerations].
    Freye E; Levy JV
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Sep; 39(9):527-37. PubMed ID: 15334329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The key-lock model of molecular biological characterization. Opiate receptors].
    Friderichs E; Strassburger W
    Pharm Unserer Zeit; 2002; 31(1):32-9. PubMed ID: 11852654
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioid modulation of ferret vagal afferent mechanosensitivity.
    Page AJ; O'Donnell TA; Blackshaw LA
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G963-70. PubMed ID: 18258789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids for chronic pain: molecular and genomic basis of actions and adverse effects.
    Ahmedzai SH; Boland J
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):117-25. PubMed ID: 18685352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of opioids in the treatment of chronic non-cancer pain.
    Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain.
    Quentin T; Debruyne D; Lelong-Boulouard V; Poisnel G; Barre L; Coquerel A
    Brain Res; 2005 Nov; 1063(1):84-95. PubMed ID: 16269137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide VF-associated satiety involves mu and kappa but not delta subtypes of opioid receptors in chicks.
    Cline MA; Sliwa LN
    Neurosci Lett; 2009 May; 455(3):195-8. PubMed ID: 19429120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of opioid analgesics.
    Moore PA
    Dent Clin North Am; 1984 Jul; 28(3):389-400. PubMed ID: 6146539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.